Skip to main content
logo
Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.350
-0.030 (-1.26%)
At close: Sep 21, 2026, 4:00 PM EDT
2.360
+0.010 (0.43%)
After-hours: Sep 21, 2026, 7:30 PM EDT

Cellectar Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
221312341641
Market Cap Growth
33.81%1.37%-63.75%112.09%-60.44%-57.05%
Enterprise Value
-102-635-02
Last Close Price
2.352.958.9783.1051.30199.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.651.260.79-2.471.681.23
P/TBV Ratio
0.741.560.90-1.971.28

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.040.03-0.040.060.01
Net Debt / Equity Ratio
-1.09-1.29-1.450.65-2.02-1.07
Net Debt / EBITDA Ratio
1.390.560.440.230.671.48
Net Debt / FCF Ratio
1.670.550.480.270.761.56
Quick Ratio
6.492.782.480.381.738.95
Current Ratio
6.662.962.580.411.799.16
Return on Equity (ROE)
-119.57%-170.27%-4693.38%--149.33%-54.92%
Return on Assets (ROA)
-58.44%-71.01%-172.36%-144.66%-61.26%-31.47%
Return on Capital Employed (ROCE)
-74.90%-224.70%-321.90%293.30%-285.60%-72.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-100.50%-174.21%-361.29%-125.65%-198.10%-59.46%
FCF Yield
-87.72%-184.87%-386.45%-97.66%-158.57%-55.98%
Buyback Yield / Dilution
-306.49%-110.67%-203.92%-73.22%-27.09%-180.20%
SEC Filings: 10-K · 10-Q